AAAAAA
Results:
1-7
|
Results: 7
Authors:
SMYTH J
SCHELLENS J
KERGER J
CALVERT H
BRUNTSCH U
HANAUSKE A
Citation: J. Smyth et al., LU-103793 HAS ACTIVITY IN MELANOMA PATIENTS, Annals of oncology, 9, 1998, pp. 557-557
Authors:
MACKEAN M
PLANTING A
TWELVES C
SCHELLENS J
ALLMAN D
OSTERWALDER B
REIGNER B
GRIFFIN T
KAYE S
VERWEIJ J
Citation: M. Mackean et al., PHASE-I AND PHARMACOLOGICAL STUDY OF INTERMITTENT TWICE-DAILY ORAL-THERAPY WITH CAPECITABINE IN PATIENTS WITH ADVANCED AND OR METASTATIC CANCER/, Journal of clinical oncology, 16(9), 1998, pp. 2977-2985
Authors:
GERRITS C
SCHELLENS J
BURRIS H
PLANTING A
VANDERBURG M
VANBEURDEN V
LOOS W
HUDSON I
FIELDS S
VONHOFF D
VERWEIJ J
Citation: C. Gerrits et al., A COMPARISON OF CLINICAL PHARMACODYNAMICS OF DIFFERENT ADMINISTRATIONSCHEDULES OF ORAL TOPOTECAN (TPT, HYCAMTIN(R)), European journal of cancer, 33, 1997, pp. 1105-1105
Authors:
HERBEN V
SCHELLENS J
SWART M
GRUIA G
BEYNEN J
HUININK WWT
Citation: V. Herben et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF IRINOTECAN (CPT11) WITH A PROLONGED (14D) INFUSION SCHEDULE, European journal of cancer, 33, 1997, pp. 1143-1143
Authors:
PLANTING A
KHO S
VANDERBURG M
GOEY H
SCHELLENS J
VANDENBENT M
VANDERGAAST A
DEBOERDENNERT M
STOTER G
VERWEIJ J
Citation: A. Planting et al., A PHASE-II STUDY OF WEEKLY HIGH-DOSE CISPLATIN COMBINED WITH ORAL ETOPOSIDE IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 40(4), 1997, pp. 347-352
Authors:
VEENHUIZEN R
OPPELAAR H
RUEVEKAMP M
SCHELLENS J
DALESIO O
STEWART F
Citation: R. Veenhuizen et al., DOES TUMOR UPTAKE OF FOSCAN DETERMINE PDT EFFICACY, International journal of cancer, 73(2), 1997, pp. 236-239
Authors:
VERWEIJ J
AAMDAL S
SCHELLENS J
KOIER I
LUND B
Citation: J. Verweij et al., CLINICAL-STUDIES WITH EO9, A NEW INDOLOQUINONE BIOREDUCTIVE ALKYLATING CYTOTOXIC AGENT, Oncology research, 6(10-11), 1994, pp. 519-523
Risultati:
1-7
|